Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone

Summary

This 2-arm study is designed to determine the maximum tolerated dose of LBH589 as a single agent and in combination with docetaxel and prednisone 5 mg twice daily (second arm) and to characterize the safety, tolerability, biologic activity and pharmacokinetic profile.

Timeline

Start

2006-05

Primary completion

—

Completion

—

Drugs

Indications